Ammar H O, Khalil R M
Department of Pharmaceutical Sciences, National Research Center, Cairo, Egypt.
Pharmazie. 1996 Mar;51(3):165-8.
The dissolution rate of six batches of commercial rifampicin products manufactured by three pharmaceutical companies was determined by both closed and open dissolution systems. The most consistent results were those obtained by the beaker method. Inter-batch as well as inter-brand variation in dissolution were found to be more evidently detected and evaluated by adopting the beaker and flow-through methods. The biovailability of these products was assessed in human subjects according to a cross-over design system. Based on the values of the correlation coefficient of the in vitro results obtained by different dissolution methods with the in vivo results, the USP rotating basket method appears to correlate best with maximum urinary excretion rate, area under excretion rate versus time curve as well as total amount of drug excreted. Thus, determination of the dissolution rate of rifampicin products by the USP rotating basket method can be considered as a reliable tool for predicting the in vivo performance of the drug.
采用密闭和开放溶出系统测定了三家制药公司生产的六批市售利福平产品的溶出速率。最一致的结果是通过烧杯法获得的。采用烧杯法和流通法能更明显地检测和评估批次间以及不同品牌间的溶出差异。根据交叉设计系统在人体受试者中评估了这些产品的生物利用度。基于不同溶出方法获得的体外结果与体内结果的相关系数值,美国药典转篮法似乎与最大尿排泄率、排泄率-时间曲线下面积以及药物排泄总量的相关性最佳。因此,采用美国药典转篮法测定利福平产品的溶出速率可被视为预测该药物体内性能的可靠工具。